Prognostic model integrating histology, systemic inflammation, and recurrence status predicts immunotherapy response in advanced non-small-cell lung cancer patients

ABSTRACT:

SUBMITTER: Moiseenko F 

PROVIDER: S-EPMC12224361 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature